China's Multicultural Population: Insights from Minority Nationalities and their Music

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/66913/2/10.1177_025576148600800105.pd

The Effect Of Vitamin B12 And Choline On The Utilization Of Carotene By The Rat

It was recognized, many years ago, that certain diseases were due to dietary deficiencies. In recent years considerable research has been directed toward the study of factors which influence the utilization of carotene and vitamin A. Vitamin A was one of the first substances discovered which would cause diseases due to a lack of it in foods. A deficiency of vitamin A results in a number of clinical symptoms j some of the symptoms due to a lack of vitamin A are loss of weight, decreased resistance to infection, and xerophthalmia. The disease caused by a specific vitamin deficiency can usually be cured by administering substances containing the particular vitamin or provitamin. There are several provitamin A pigments (carotenoids) found in plants. The most active of these pigments, as a precursor for vitamin A, is B-carotene. The following structures of ^3-carotene and vitamin A are those established by Kuhn and Karrer (l)

Warrant for Arrest

Warrant for the arrest of Jim Butler in Hinds County, Mississippi, issued by Justice of the Peace C. Standifer.https://scholarsjunction.msstate.edu/mss-williams-papers/1125/thumbnail.jp

Methylnaltrexone in the treatment of opioid-induced constipation

Constipation is a significant problem related to opioid medications used to manage pain. This review attempts to outline the latest findings related to the therapeutic usefulness of a μ opioid receptor antagonist, methylnaltrexone in the treatment of opioid-induced constipation. The review highlights methylnaltrexone bromide (Relistor™; Progenics/Wyeth) a quaternary derivative of naltrexone, which was recently approved in the United States, Europe and Canada. The Food and Drug Administration in the United States approved a subcutaneous injection for the treatment of opioid bowel dysfunction in patients with advanced illness who are receiving palliative care and when laxative therapy has been insufficient. Methylnaltrexone is a peripherally restricted, μ opioid receptor antagonist that accelerates oral–cecal transit in patients with opioid-induced constipation without reversing the analgesic effects of morphine or inducing symptoms of opioid withdrawal. An analysis of the mechanism of action and the potential benefits of using methylnaltrexone is based on data from published basic research and recent clinical studies

Weed Control for Reduced Tillage Systems

PDF pages:

The Appropriateness of Different Modes of Strategy from a Product-Market Perspective

Strategy-making is an important yet complex task. The present research examines the issue of strategy mode, that is, the manner or style in which strategy is determined in an organization. Prior researchers have proposed various typologies for strategy modes. However, research into which strategy modes are appropriate to what kinds of firm situations and contexts has been limited. Specifically, there has been no research that explores strategy modes from a marketing environment perspective. Given that research at the intersection of marketing and management disciplines has often produced mutually beneficial, rich insights, we approach strategy modes from a product-market perspective and examine the normative appropriateness of different strategy modes with reference to firms\u27 external and internal environments. The research also explores the relevance and value of combining various strategy modes in regard to different stages of the product-market life cycle. In exploring strategy modes and their combinatory influences from a product-market perspective, we develop specific propositions. The paper concludes with a discussion of implications for academics and practitioners

Incorporating Tailored Interactive Patient Solutions Using Interactive Voice Response Technology to Improve Statin Adherence: Results of a Randomized Clinical Trial in a Managed Care Setting

Abstract The current study presents the impact of a behavior change program to increase statin adherence using interactive voice response (IVR) technology. Subjects were affiliated with a large health benefit company, were prescribed a statin (index) and had no lipid-lowering pharmacy claims in the previous 6 months, and were continuously enrolled in the plan for 12 months prior and 6 months post index statin. Potential subjects (1219) were contacted by the IVR system; 497 gave informed consent. Subjects were asked to respond to 15 questions from the IVR that were guided by several behavior change theories. At the conclusion of the questions, subjects were randomly assigned to either a control group (n=244), who received generic feedback at the conclusion of the call and were then mailed a generic cholesterol guide, or an experimental group (n=253), who received tailored feedback based on their cholesterol-related knowledge, attitudes, beliefs, and perceived barriers to medication adherence, and were mailed a tailored guide that reinforced similar themes. Subjects in the experimental group had the opportunity to participate in 2 additional tailored IVR support calls. The primary dependent variable was 6-month point prevalence, defined as claims evidence of a statin on days 121-180 post index statin. Subjects in the experimental group had a significantly higher 6-month point prevalence than the controls (70.4% vs. 60.7%, P<0.05). Results of this study suggest that a behavioral support program using IVR technology can be a cost-effective modality to address the important public health problem of patient nonadherence with statin medication. (Population Health Management 2009;12:241-254)Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/78104/1/pop.2008.0046.pd